Government of Nepal
Ministry of Health and Population
Department of Health Services
Epidemiology and Disease Control Division
Protocol for using Bamlanivimab & Etesevimab Anti-SARS-Cov-2 Monoclonal Antibodies
Jan 1
It contains reported infectious diseases, syndromes and public health events.